HealthEquity Gestione
Gestione criteri di controllo 3/4
HealthEquity Il CEO è Jon Kessler, nominato in Feb2014, e ha un mandato di 10.75 anni. la retribuzione annua totale è $ 13.45M, composta da 5.2% di stipendio e 94.8% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.35% delle azioni della società, per un valore di $ 31.87M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 3 anni e 7.7 anni.
Informazioni chiave
Jon Kessler
Amministratore delegato
US$13.4m
Compenso totale
| Percentuale dello stipendio del CEO | 5.2% |
| Mandato del CEO | 10.8yrs |
| Proprietà del CEO | 0.4% |
| Durata media del management | 3yrs |
| Durata media del Consiglio di amministrazione | 7.7yrs |
Aggiornamenti recenti sulla gestione
Recent updates
HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 41% Below Their Intrinsic Value Estimate
Nov 20
HealthEquity: High Marks For Recent Profit Growth
Nov 20We Think HealthEquity (NASDAQ:HQY) Can Stay On Top Of Its Debt
Oct 31Getting In Cheap On HealthEquity, Inc. (NASDAQ:HQY) Might Be Difficult
Aug 30HealthEquity: Compelling Catalysts, Fairly Valued, Reiterate Buy
Aug 27Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?
Jul 13We Think Some Shareholders May Hesitate To Increase HealthEquity, Inc.'s (NASDAQ:HQY) CEO Compensation
Jun 21Earnings Beat: HealthEquity, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Jun 07HealthEquity: A Trading Vehicle Performing As Expected, Strong Growth Hard To Ignore
Jun 04HealthEquity: Strong Growth And Healthy Cash Flows Changed My Mind
May 29Are Investors Undervaluing HealthEquity, Inc. (NASDAQ:HQY) By 48%?
May 03Market Participants Recognise HealthEquity, Inc.'s (NASDAQ:HQY) Revenues
Apr 11HealthEquity: Multiple Compression Has Finally Made It A Buy
Mar 21Investors Appear Satisfied With HealthEquity, Inc.'s (NASDAQ:HQY) Prospects
Dec 28Is HealthEquity (NASDAQ:HQY) A Risky Investment?
Nov 17HealthEquity, Inc.'s (NASDAQ:HQY) Intrinsic Value Is Potentially 51% Above Its Share Price
Oct 26Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?
Jul 27HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 37% Below Their Intrinsic Value Estimate
Jul 07Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?
Apr 18Estimating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)
Mar 14Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?
Dec 24Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?
Dec 02Is HealthEquity, Inc. (NASDAQ:HQY) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 11These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively
Sep 08HealthEquity Non-GAAP EPS of $0.33 in-line, revenue of $206.1M beats by $2.22M
Sep 06HealthEquity: Asymmetry In Valuation Continues To Widen
Aug 25HealthEquity COO steps down, CEO to assume his responsibilities
Aug 02Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?
Jul 27Calculating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)
Jul 06These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively
May 24Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jul 31 2024 | n/a | n/a | US$106m |
| Apr 30 2024 | n/a | n/a | US$80m |
| Jan 31 2024 | US$13m | US$700k | US$56m |
| Oct 31 2023 | n/a | n/a | US$29m |
| Jul 31 2023 | n/a | n/a | US$13m |
| Apr 30 2023 | n/a | n/a | -US$8m |
| Jan 31 2023 | US$13m | US$700k | -US$26m |
| Oct 31 2022 | n/a | n/a | -US$59m |
| Jul 31 2022 | n/a | n/a | -US$62m |
| Apr 30 2022 | n/a | n/a | -US$55m |
| Jan 31 2022 | US$10m | US$700k | -US$44m |
| Oct 31 2021 | n/a | n/a | -US$6m |
| Jul 31 2021 | n/a | n/a | US$723k |
| Apr 30 2021 | n/a | n/a | US$4m |
| Jan 31 2021 | US$9m | US$667k | US$9m |
| Oct 31 2020 | n/a | n/a | US$3m |
| Jul 31 2020 | n/a | n/a | -US$20m |
| Apr 30 2020 | n/a | n/a | -US$332k |
| Jan 31 2020 | US$5m | US$500k | US$40m |
| Oct 31 2019 | n/a | n/a | US$53m |
| Jul 31 2019 | n/a | n/a | US$90m |
| Apr 30 2019 | n/a | n/a | US$93m |
| Jan 31 2019 | US$5m | US$483k | US$74m |
| Oct 31 2018 | n/a | n/a | US$67m |
| Jul 31 2018 | n/a | n/a | US$61m |
| Apr 30 2018 | n/a | n/a | US$56m |
| Jan 31 2018 | US$4m | US$400k | US$47m |
Compensazione vs Mercato: La retribuzione totale di Jon ($USD 13.45M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 7.74M ).
Compensazione vs guadagni: La retribuzione di Jon è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Jon Kessler (56 yo)
10.8yrs
Mandato
US$13,448,018
Compensazione
Mr. Jon Kessler is a Member of the Board of Managers at HealthEquity Advisors, LLC. He has been the Chief Executive Officer and President of HealthEquity, Inc. since February 2014. Mr. Kessler founded Wage...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President | 10.8yrs | US$13.45m | 0.35% $ 31.9m | |
| Founder & Vice Chairman | 22yrs | US$3.04m | 0.94% $ 85.4m | |
| CFO & Executive VP | 1.2yrs | US$5.23m | 0.0086% $ 784.7k | |
| Executive VP & CTO | 2.7yrs | US$4.81m | 0.0033% $ 298.6k | |
| Executive VP | 8.2yrs | US$2.64m | 0.044% $ 4.0m | |
| Vice President of Investor Relations | no data | Nessun dato | Nessun dato | |
| Executive Vice President of Sales & Relationship Management | 3.3yrs | Nessun dato | Nessun dato | |
| Executive Vice President of Corporate Development & Strategy | 7.6yrs | Nessun dato | Nessun dato | |
| Executive VP & Chief Marketing Officer | 2.8yrs | Nessun dato | Nessun dato | |
| Executive VP & Chief People Officer | 1.6yrs | Nessun dato | Nessun dato | |
| Senior VP & Head of Product | 2yrs | Nessun dato | Nessun dato | |
| Executive VP & Chief Security Officer | no data | Nessun dato | Nessun dato |
3.0yrs
Durata media
56yo
Età media
Gestione esperta: Il team dirigenziale di HQY è considerato esperto (durata media dell'incarico 3 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President | 15.7yrs | US$13.45m | 0.35% $ 31.9m | |
| Founder & Vice Chairman | 22yrs | US$3.04m | 0.94% $ 85.4m | |
| Independent Director | 8.2yrs | US$297.50k | 0.062% $ 5.7m | |
| Independent Non-Executive Chairman | 9.2yrs | US$362.50k | 0.065% $ 6.0m | |
| Independent Director | 2.2yrs | US$272.50k | 0.0050% $ 457.9k | |
| Independent Director | 10.3yrs | US$290.00k | 0.037% $ 3.3m | |
| Independent Director | 3.9yrs | US$280.00k | 0.035% $ 3.2m | |
| Independent Director | 7.3yrs | US$278.87k | 0.017% $ 1.6m | |
| Independent Director | 6.6yrs | US$275.00k | 0.012% $ 1.1m | |
| Independent Director | 2.5yrs | US$272.50k | 0.0096% $ 875.8k |
7.7yrs
Durata media
62.5yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di HQY sono considerati esperti (durata media dell'incarico 7.7 anni).